chartexchange

PRCT
PROCEPT BioRobotics Corporation Common Stock
stockNASDAQ

Market OpenNov 19, 2026 3:17:41 PM EST
25.70USD+2.065%(+0.52)897,428
24.25Bid29.62Ask5.37Spread
Loading…
Loading…
Healthcare
Medical Devices
HQ
Redwood City, CA, USA
Previous Close
$25.18
Beta
0.97
52-Week High
$38.11 2025-12-05
52-Week Low
$16.67 2026-07-24
SMA 50
$19.67
SMA 200
$22.83
Avg. Vol 10D
1.68M
Avg. Vol 30D
1.37M
Avg. Vol 90D
1.42M
Relative Vol
0.65
54.87M
0.4100%
1,200,000
3,800
PRCT Profile

based in silicon valley, procept biorobotics is a privately held surgical robotics company enabling better patient care by developing transformative solutions in urology. with an initial focus on benign prostatic hyperplasia (bph), the company's first product, the aquabeam system delivering aquablation therapy, is the world's first commercially available minimally invasive surgical robot providing autonomous tissue removal to safely and effectively treat bph. aquablation therapy offers predictable and reproducible outcomes, independent of prostate anatomy or surgeon experience.

PRCT Performance
PeriodPriceDateChangeBeta
1W23.512026-11-12+9.04%3.064
1M18.282026-10-19+40.23%1.626
3M21.912026-08-19+17.00%1.479
6M25.912026-05-19-1.06%0.663
1Y27.932025-11-19-8.22%0.967
2Y93.572024-11-19-72.60%—
5Y40.682021-11-19-36.98%1.238
PRCT Stock Summary

PROCEPT BioRobotics Corporation Common Stock (NASDAQ:PRCT) stock price today is $25.64, and today's volume is 895,198. PRCT is up 1.807% today. The 30 day average volume is 1.37M. PRCT market cap is $1.47B with 57.54M shares outstanding.